Renoprotective Effects of DPP-4 Inhibitors

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely used in the treatment of patients with type 2 diabetes (T2D). DPP-4 inhibitors reduce glucose levels by inhibiting degradation of incretins. DPP-4 is a u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawanami, Daiji, Takashi, Yuichi, Takahashi, Hiroyuki, Motonaga, Ryoko, Tanabe, Makito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915260/
https://www.ncbi.nlm.nih.gov/pubmed/33562528
http://dx.doi.org/10.3390/antiox10020246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915260/
https://www.ncbi.nlm.nih.gov/pubmed/33562528
http://dx.doi.org/10.3390/antiox10020246

Ejemplares similares